Skip to main content
. 2020 Jan 21;26(3):307–323. doi: 10.3748/wjg.v26.i3.307

Table 2.

Association between nucleotide excision repair polymorphisms and colorectal cancer risk in the validation stage1, n (%)

SNP genotype NCBI Ref CRC CON P value OR (95%CI)
DDB2
rs2029298 n = 849 n = 849
GG 32 (37.2) 393 (46.3) 385 (45.3) 1 (Ref)
GA 38 (44.2) 359 (42.3) 368 (43.3) 0.650 0.95 (0.78-1.17)
AA 16 (18.6) 97 (11.4) 96 (11.3) 0.919 0.98 (0.72-1.35)
GA + AA vs GG 0.677 0.96 (0.79-1.16)
AA vs GA + GG 0.980 1.00 (0.74-1.36)
PHWE 0.584 0.570
ERCC1
rs11615 n = 850 n = 847
CC 54 (62.8) 518 (60.9) 494 (58.3) 1 (Ref)
CT 24 (27.9) 293 (34.5) 305 (36.0) 0.355 0.91 (0.74-1.11)
TT 8 (9.3) 39 (4.6) 48 (5.7) 0.248 0.77 (0.50-1.20)
CT + TT vs CC 0.244 0.89 (0.73-1.08)
TT vs CT + CC 0.321 0.80 (0.52-1.24)
PHWE 0.200 0.919
rs735482 n = 836 n = 838
CC 18 (20.9) 169 (20.2) 168 (20.0) 1 (Ref)
CA 40 (46.5) 405 (48.4) 403 (48.1) 0.966 1.00 (0.77-1.28)
AA 28 (32.6) 262 (31.3) 267 (31.9) 0.856 0.98 (0.74-1.28)
CA + AA vs CC 0.920 0.99 (0.78-1.26)
AA vs CA + CC 0.812 0.98 (0.79-1.20)
PHWE 0.752 0.477
ERCC2
rs1052555 n = 852 n = 851
CC NA 767 (90.0) 759 (89.2) 1 (Ref)
CT NA 84 (9.9) 91 (10.7) 0.605 0.92 (0.67-1.26)
TT NA 1 (0.1) 1 (0.1) 0.970 0.95 (0.06-15.21)
CT + TT vs CC 0.602 0.92 (0.67-1.26)
TT vs CT + CC 0.971 0.95 (0.06-15.22)
PHWE NA 0.307
rs50871 n = 838 n = 845
TT 40 (46.5) 429 (51.2) 451 (53.4) 1 (Ref)
TG 36 (41.9) 337 (40.2) 358 (42.4) 0.922 0.99 (0.81-1.21)
GG 10 (11.6) 72 (8.6) 36 (4.3) 0.001 2.09 (1.37-3.19)
TG + GG vs TT 0.374 1.09 (0.90-1.32)
GG vs TG + TT < 0.001 2.08 (1.38-3.15)
PHWE 1.000 0.001
ERCC5
rs1047768 n = 839 n = 845
CC 8 (9.3) 75 (8.9) 71 (8.4) 1 (Ref)
CT 30 (34.9) 348 (41.5) 351 (41.5) 0.735 0.94 (0.66-1.35)
TT 48 (55.8) 416 (49.6) 423 (50.1) 0.708 0.94 (0.66-1.33)
CT + TT vs CC 0.717 0.94 (0.67-1.32)
TT vs CT + CC 0.822 0.98 (0.81-1.19)
PHWE 0.480 0.880
rs2094258 n = 843 n = 841
GG 38 (44.2) 307 (36.4) 326 (38.8) 1 (Ref)
GA 42 (48.8) 409 (48.5) 392 (46.6) 0.389 1.10 (0.89-1.35)
AA 6 (7.0) 127 (15.1) 123 (14.6) 0.615 1.08 (0.80-1.45)
GA + AA vs GG 0.370 1.10 (0.90-1.33)
AA vs GA + GG 0.837 1.03 (0.79-1.35)
PHWE 0.403 0.770
rs2228959 n = 841 n = 851
CC 74 (86.0) 754 (89.7) 782 (91.9) 1 (Ref)
CA 12 (14.0) 83 (9.9) 62 (7.3) 0.051 1.41 (1.00-1.99)
AA 0 (0.0) 4 (0.5) 7 (0.8) 0.408 0.59 (0.17-2.04)
CA + AA vs CC 0.095 1.33 (0.95-1.85)
AA vs CA + CC 0.383 0.58 (0.17-1.98)
PHWE 1.000 < 0.001
rs2296147 n = 844 n = 847
TT 52 (60.5) 508 (60.2) 517 (61.0) 1 (Ref)
TC 32 (37.2) 294 (34.8) 289 (34.1) 0.684 1.04 (0.85-1.28)
CC 2 (2.3) 42 (5.0) 41 (4.8) 0.904 1.03 (0.66-1.61)
TC + CC vs TT 0.679 1.04 (0.86-1.27)
CC vs TC + TT 0.952 1.01 (0.65-1.58)
PHWE 0.439 0.940
rs873601 n = 842 n = 837
GG 16 (18.6) 230 (27.3) 223 (26.6) 1 (Ref)
GA 48 (55.8) 435 (51.7) 413 (49.3) 0.807 1.03 (0.82-1.29)
AA 22 (25.6) 177 (21.0) 201 (24.0) 0.310 0.87 (0.66-1.14)
GA + AA vs GG 0.849 0.98 (0.79-1.22)
AA vs GA + GG 0.155 0.85 (0.67-1.07)
PHWE 0.439 0.719
XPA
rs10817938 n = 823 n = 822
TT 58 (67.4) 511 (62.1) 547 (66.5) 1(Ref)
TC 24 (27.9) 259 (31.5) 241 (29.3) 0.231 1.14 (0.92-1.41)
CC 4 (4.7) 53 (6.4) 34 (4.1) 0.021 1.70 (1.08-2.66)
TC + CC vs TT 0.071 1.21 (0.98-1.48)
CC vs TC + TT 0.033 1.62 (1.04-2.52)
PHWE 0.655 0.257
rs3176629 n = 847 n = 852
CC 68 (79.1) 689 (81.3) 706 (82.9) 1 (Ref)
CT 18 (20.9) 151 (17.8) 133 (15.6) 0.240 1.17 (0.90-1.51)
TT 0 (0.0) 7 (0.8) 13 (1.5) 0.225 0.56 (0.22-1.42)
CT + TT vs CC 0.399 1.11 (0.87-1.43)
TT vs CT + CC 0.205 0.55 (0.22-1.39)
PHWE 0.752 0.024
XPC
rs2607775 n = 840 n = 850
CC 76 (84.5) 755 (89.9) 792 (93.2) 1(Ref)
CG 12 (13.3) 80 (9.5) 56 (6.6) 0.027 1.49 (1.05-2.13)
GG 2 (2.2) 5 (0.6) 2 (0.2) 0.219 2.81 (0.54-14.56)
CG + GG vs CC 0.016 1.54 (1.09-2.18)
GG vs CG + CC 0.238 2.69 (0.52-13.95)
PHWE 0.251 0.343

1P was adjusted by gender and age. Statistically significant associations are in bold (P < 0.05). SNP: Single nucleotide polymorphism; NCBI Ref: Reference frequency of the SNPs in healthy controls (Beijing Han, China, NCBI database); CRC: Colorectal cancer; CON: Control; OR: Odds ratio; CI: Confidence interval; PHWE: Hardy-Weinberg Equilibrium in control group; NA: Not available.